These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32969902)

  • 1. 68Ga-DOTATATE and 18F-FDG in Castleman Disease.
    Verçosa AFA; Flamini MEDM; Loureiro LVM; Flamini RC
    Clin Nucl Med; 2020 Nov; 45(11):868-870. PubMed ID: 32969902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
    Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
    J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
    Fu Z; Liu M; Chen X; Yang X; Li Q
    Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
    Pan Q; Zhang X; Luo Y; Ma Y; Li F
    Clin Nucl Med; 2019 Feb; 44(2):164-166. PubMed ID: 30516666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
    Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
    Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropic Hormone-Secreting Neuroendocrine Tumor of the Rectum Demonstrated on 68Ga-DOTATATE and 18F-FDG PET Imaging.
    Szajer J; Yung G; Russo R; Mansberg R
    Clin Nucl Med; 2017 Oct; 42(10):773-775. PubMed ID: 28759524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Prognostic Value of PET/CT Imaging with Combination of
    Zhang P; Yu J; Li J; Shen L; Li N; Zhu H; Zhai S; Zhang Y; Yang Z; Lu M
    Contrast Media Mol Imaging; 2018; 2018():2340389. PubMed ID: 29681780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Brown Tumor on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
    Yao X; Ou X
    Clin Nucl Med; 2022 Jan; 47(1):88-89. PubMed ID: 34874352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of Extramedullary Plasmacytomas Involving Lymph Nodes and Pancreas Revealed by 68Ga-DOTATATE and 18F-FDG PET/CT.
    Pan Q; Luo Y; Li J; Zhang S; Li F
    Clin Nucl Med; 2018 Dec; 43(12):936-938. PubMed ID: 30179917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
    Dadgar H; Norouzbeigi N; Ahmadzadehfar H; Assadi M
    Clin Nucl Med; 2020 Aug; 45(8):e363-e364. PubMed ID: 32558717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT Findings in TAFRO Syndrome.
    Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
    Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic Castleman Disease on FDG PET/CT.
    Li F; Xiao L; Cai H; Li L
    Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT.
    Lu Y
    Clin Nucl Med; 2019 Nov; 44(11):914-915. PubMed ID: 31306189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
    Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
    Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT imaging with 18F-FDG in Castleman disease.
    Delgado A; Mesa J; Guayambuco S; Rodriguez T; Fernández I; Rodeño E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):200-1. PubMed ID: 26614744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.